Founder and CEO, has 15 years of R&D experience in early stage Medtech companies, including R&D roles at Thoratec (acquired by Abbot) and Outset Medical (IPO). He excels at developing and launching paradigm-changing technology, setting up manufacturing processes, managing quality systems, and training physicians. Mr. Hsu holds a B.S. in Mechanical Engineering from the University of California, Berkeley.

Director of Sales, brings over 20 years of experience in the medical device industry. Mr. Lott developed and successfully executed the launch of Rezum in Florida. He specializes in product launch, sales leadership, and team building. He has worked in sales or sales leadership for early-stage companies like Saluda Medical, Axonics, and Mi Medx, and in large Medtech corporations like Medtronic, Dendreon, and Hollister. He has won numerous national sales and sales leadership awards and has mentored and trained countless high-performing sales representatives. Mr. Lott holds a B.S. from Catawba College and an M.B.A. from Gardner-Webb University.

Leads QA, Regulatory, and Clinical, with 33 years of experience helping multiple companies obtain clearances. Ms. Hoy was previously the Executive VP of Regulatory/Quality/Clinical at Cynosure (Hologic), and VP of RA/QA at Cutera, Xoft, and Lumenis. She is a graduate of the University of New Mexico.

Has over 15 years of experience in the medical device industry. She has worked with leaders like Covidien/Medtronic and guided startups in meeting FDA and global standards. Ms. Kaulback has led audits and driven continuous improvement of quality systems, supporting the development of innovative solutions. Ms. Kaulback holds a B.A. in Molecular, Cellular, and Developmental Biology from the University of California, Santa Cruz, and an M.B.A. from Saint Mary’s College of California.

Brings over 30 years of Engineering and Operations experience in the Medtech industry. Before joining Aulea Medical, he served as Vice President of Operations at Spire Health (acquired by Wellinks) where he oversaw domestic and international operations. Prior to that, Mr. Lagasca held Engineering and Operations leadership positions at Nevro Corporation, Invuity Corporation (acquired by Stryker) and Thoratec Corporation (acquired by Abbott), and he served in engineering positions at Target Therapeutics (now Boston Scientific) and Lifescan Inc., a Johnson & Johnson subsidiary. He holds a BS in Electrical Engineering from SanFrancisco State University.

Mr. Esch has 32+ years of experience in board leadership, starting Medtech companies, inventing novel medical devices, and leading R&D and product management teams. He is the Founder, Board Chair, CEO & CFO of Venclose (acquired by Becton Dickinson) for chronic venous insufficiency office-based treatment. Mr. Esch has also held senior leadership roles at Stryker Neurovascular and Covidien (now Medtronic). He holds a B.S. in Mechanical Engineering from the University of California, San Diego, and an M.S. in Materials Science & Engineering from Stanford University.

Ms. Hou  has 25 years of experience investing in innovative technology that makes a difference in the lives of patients. She has held senior leadership roles in the commercial real estate industry, and serves on the board of Interlink Electronics. Ms. Hou holds a B.S. in Hotel Administration from Cornell University.

Mr. Jan is a serial entrepreneur and early-stage investor who brings insights and capital. He is currently Founder & Managing Director at Taiwan Global Angels, an Advisor to startup founders at Berkeley SkyDeck, a Senior Advisor to the Dean of the UC Berkeley School of Public Health, and a Visiting Scholar at UC Berkeley’s Bioengineering and Biomedical Engineering departments. Mr. Jan has a PhD and MS in Biomedical Engineering/EE and a BS in Physics from National Taiwan University, and an MBA from National Chengchi University.